Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Umbricht

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective TrialKala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Breast Cancer Research : BCR|December 5, 2024
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situMarija Debeljak, Soonweng Cho, Bradley M Downs, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2005
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancerMingzhao Xing, William H Westra, Ralph P Tufano, et al.
Cancer Research Communications|September 1, 2022
Development of an automated liquid biopsy assay for methylated markers in advanced breast cancerMary Jo Fackler, Suzana Tulac, Neesha Venkatesan, et al.
Thyroid : Official Journal of the American Thyroid Association|March 8, 2016
Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery CentersPatricia Aragon Han, Hyun-seok Kim, Soonweng Cho, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centersCarol Li, Patricia Aragon Han, Kathleen C Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast CancerHyun-Seok Kim, Christopher B Umbricht, Peter B Illei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
DNA Methylation Markers for Breast Cancer Detection in the Developing WorldBradley M Downs, Claudia Mercado-Rodriguez, Ashley Cimino-Mathews, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective TrialKala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Breast Cancer Research : BCR|December 5, 2024
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situMarija Debeljak, Soonweng Cho, Bradley M Downs, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2005
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancerMingzhao Xing, William H Westra, Ralph P Tufano, et al.
Cancer Research Communications|September 1, 2022
Development of an automated liquid biopsy assay for methylated markers in advanced breast cancerMary Jo Fackler, Suzana Tulac, Neesha Venkatesan, et al.
Thyroid : Official Journal of the American Thyroid Association|March 8, 2016
Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery CentersPatricia Aragon Han, Hyun-seok Kim, Soonweng Cho, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centersCarol Li, Patricia Aragon Han, Kathleen C Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast CancerHyun-Seok Kim, Christopher B Umbricht, Peter B Illei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
DNA Methylation Markers for Breast Cancer Detection in the Developing WorldBradley M Downs, Claudia Mercado-Rodriguez, Ashley Cimino-Mathews, et al.
Pageof 5